Skip to main content
NCBI home page
The Journal of Headache and Pain logoLink to The Journal of Headache and Pain
. 2008 Aug 19;9(5):309–315. doi: 10.1007/s10194-008-0059-1

Development of a self-reporting questionnaire, BURMIG, to evaluate the burden of migraine

Colette Andrée 1,2, Michel Vaillant 1, Christelle Rott 1, Zaza Katsarava 3, Peter S Sándor 4,✉
PMCID: PMC3452196  PMID: 18712275

Abstract

We developed a 77-item self-reporting questionnaire to assess the burden of migraine (BURMIG), including headache characteristics, migraine associated disability, comorbidities, management, and the consequences on the patients’ lives. We translated BURMIG into four languages (French, Portuguese, German and English) and tested it in 130 headache patients (20 pain clinic, 17 primary care and 93 general public) in Luxembourg. We performed a linguistic and a face-content validation and tested the questionnaire for its comprehensiveness, internal consistency and for its retest-reliability at an interval of 1 month (completion rates were 79.6 and 76.4%, for test and retest, respectively). Retest-reliability for the different parts of the questionnaire varied between 0.6 and 1.0 (Kappa coefficient), with an intracorrelation coefficient of 0.7–1.0. The internal consistency was between 0.74 and 0.91 (Cronbach’s alpha). The questionnaire BURMIG is suitable to evaluate the burden of migraine and can be used in English, German, French and Portuguese.

Electronic supplementary material

The online version of this article (doi:10.1007/s10194-008-0059-1) contains supplementary material, which is available to authorized users.

Keywords: Headache, Questionnaire, Burden, Validation, English, German, French, Portuguese

Full Text

The Full Text of this article is available as a PDF (214.8 KB).

Acknowledgments

The authors are indebted to all physicians, psychologist, pharmacists and patient organizations for their contributions to this study and are especially grateful for the help offered by T. Steiner, Ch. Pull, S. Chatterjis, R.Lipton, J. Schoenen, and A. Mc Gregor. We also thank particularly the ‘comité de pilotage’: Dr Alexandre Bisdorff, Hôpital Emil Mayrisch, Service Neurologie, Dr Catherine Boisanté, Centre Hospitalier, Centre De Traitement de la Douleur, Dr Robert Goerens, Direction de La Sante, Mme Marie-Anne Kaiffer, Patientevertriedung, Mme Marie-Lise Lair, Crp-Santé CES, Dr Nicole Majery, Service de Sante au Travail Multisectoriel, Mme Joséane Martens-Paulus, Syndicat des Pharmaciens, Dr René Metz, Centre Hospitalier, Service Neurologie, Prof Charles Pull, Centre Hospitalier, Service Psychiatrie Ambulatoire et de Liaison, Mme Véronique Schambourg, Syndicat des Pharmaciens, Dr Yolande Wagener, Direction de la Santé. The study was funded by the Luxembourg Ministry of Research and the Swiss Migraine Trust Foundation.

Conflict of interest

None.

Footnotes

Colette Andrée and Michel Vaillant have contributed equally to the work.

Contributor Information

Colette Andrée, Email: migraine_action@vtxmail.ch.

Peter S. Sándor, Email: Peter.Sandor@usz.ch

References

  • 1.Goadsby PJ, Lipton R, Ferrari MD. Migraine—current understanding and treatment. N Engl J Med. 2002;346(4):257–270. doi: 10.1056/NEJMra010917. [DOI] [PubMed] [Google Scholar]
  • 2.Headache disorders and Public Health. Education and Management, Implications. Geneva: WHO World Health Organisation, Department of Mental Health and Substance Dependence WHO/MSD/MBD/00.9. Report No.: WHO/MSD/MBD/00.9
  • 3.WHO (2002) The world health report 2001: mental health, New Understanding, New Hope. WHO, Geneva
  • 4.Mounstephen AH, Harrison RK. A study of migraine and its effects in a working population. Occup Med (Lond) 1995;45:311–317. doi: 10.1093/occmed/45.6.311. [DOI] [PubMed] [Google Scholar]
  • 5.Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FF. Societal perspective on the burden of migraine in The Netherlands. Pharmacoeconomics. 1995;7:170–179. doi: 10.2165/00019053-199507020-00008. [DOI] [PubMed] [Google Scholar]
  • 6.Lipton RB, Amatniek JC, Ferrari MD, Migraine GM. Identifying and removing barriers to care. Neurology. 1994;44:S63–S68. [PubMed] [Google Scholar]
  • 7.Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638–645. doi: 10.1046/j.1526-4610.2001.041007638.x. [DOI] [PubMed] [Google Scholar]
  • 8.Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics. 1992;2:67–76. doi: 10.2165/00019053-199202010-00008. [DOI] [PubMed] [Google Scholar]
  • 9.Rasmussen BK. Epidemiology and socio-economic impact of headache. Cephalalgia. 1992;19(Suppl 25):20–23. doi: 10.1177/0333102499019s2505. [DOI] [PubMed] [Google Scholar]
  • 10.Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the National Health Interview Survey. Headache. 1993;33:29–35. doi: 10.1111/j.1526-4610.1993.hed3301029.x. [DOI] [PubMed] [Google Scholar]
  • 11.Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci. 1993;20:131–137. doi: 10.1017/s0317167100047697. [DOI] [PubMed] [Google Scholar]
  • 12.Kryst S, Scherl E. A population-based survey of the social and personal impact of headache. Headache. 1994;34:344–350. doi: 10.1111/j.1526-4610.1994.hed3406344.x. [DOI] [PubMed] [Google Scholar]
  • 13.Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia. 2003;23:429–440. doi: 10.1046/j.1468-2982.2003.00543.x. [DOI] [PubMed] [Google Scholar]
  • 14.Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology. 2003;61:375–382. doi: 10.1212/01.wnl.0000078940.53438.83. [DOI] [PubMed] [Google Scholar]
  • 15.WHODAS-II, Disability Assessment Schedule (online). Available at: http://www.who.int/icidh/whodas/
  • 16.Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56:S20–S28. doi: 10.1159/000048126. [DOI] [PubMed] [Google Scholar]
  • 17.Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Boardman HF, Thomas E, Millson DS, MacGregor EA, Laughey WF, Croft PR. North Staffordshire Headache Survey: development, reliability and validity of a questionnaire for use in a general population survey. Cephalalgia. 2003;23:325–331. doi: 10.1046/j.1468-2982.2003.00536.x. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

10194_2008_59_MOESM1_ESM.pdf (691.3KB, pdf)

MOESM1 BURMIG questionnaire (PDF 691 kb)

Articles from The Journal of Headache and Pain are provided here courtesy of BMC

RESOURCES